Top Markets
Coin of the day
Neovasc Inc. Neovasc Inc.

Neovasc Inc.

NVCN
Clasificación en acciones #17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
Precio por acción
$29.82
Última sincronización: 2023-04-11
Capitalización bursátil
$223.68M
Cambio (1 día)
1.21%
Cambio (1 año)
0.00%
País
CA
Comercio Neovasc Inc. (NVCN)

Categoría

Ganancias de Neovasc Inc. (NVCN)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Neovasc Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Neovasc Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
$1.42B -
US